Abstract
Oxidative stress may be involved in breast carcinogenesis. Myeloperoxidase (MPO) is an endogenous oxidant enzyme that generates reactive oxygen species (ROS). A single nucleotide polymorphism (SNP) G-463A in the promoter region has been associated with a decrease in risk of breast cancer. We assessed the association between this polymorphism and breast cancer risk in a nested case-control study within the Nurses’ Health Study (1,269 incident breast cancer cases and 1,761 matched controls). We further investigated potential gene-gene and gene-environment interactions. There were no significant associations between MPO or COMT genotypes and risk of breast cancer. However, the combination of a priori hypothesized low-risk genotypes in MPO and COMT genes was associated with a marginally significant decrease in breast cancer risk (OR, 0.28; 95% CI, 0.08–1.00). Dietary intake and plasma antioxidant levels may modify the association between the MPO polymorphism and breast cancer risk. Although the test for departure from multiplicative interaction was not significant, inverse associations with MPO genotype were more pronounced among women who consumed higher amounts of total fruits and vegetables (OR, 0.58; 95% CI, 0.30–1.12); this association was not found among the low-consumption group (OR, 1.11; 95% CI, 0.63–1.96). The relative risk associated with the MPO homozygous variant genotype was 0.44 (95% CI, 0.18–1.09) for women who had the highest level of plasma carotenoids. Results from this study suggest that exogenous and endogenous modulators of oxidative stress may modify the association between the MPO polymorphism and breast cancer risk. Further research is needed to confirm these possible associations.
Similar content being viewed by others
References
Ambrosone CB (2000) Oxidants and antioxidants in breast cancer. Antioxid Redox Signal 2:903–917
Feig DI, Reid TM, Loeb LA (1994) Reactive oxygen species in tumorigenesis. Cancer Res 54:1890s–1894s
Cooke MS, Evans MD, Dizdaroglu M et al (2003) Oxidative DNA damage: mechanisms, mutation, and disease. Faseb J 17:1195–1214
de Zwart LL, Meerman JH, Commandeur JN et al (1999) Biomarkers of free radical damage applications in experimental animals and in humans. Free Radic Biol Med 26:202–226
Lancaster JR Jr, Xie K (2006) Tumors face NO problems? Cancer Res 66:6459–6462
Arnhold J (2004) Properties, functions, and secretion of human myeloperoxidase. Biochemistry (Mosc) 69:4–9
Gilbert DL CC (1999) Reactive oxygen species in biological systems: an interdisciplinary approach. Kluwer Academic/Plenum Publishers, New York
Klebanoff SJ (2005) Myeloperoxidase: friend and foe. J Leukoc Biol 77:598–625
Kiyohara C, Yoshimasu K, Takayama K et al (2005) NQO1, MPO, and the risk of lung cancer: a HuGE review. Genet Med 7:463–478
Hansson M, Olsson I, Nauseef WM (2006) Biosynthesis, processing, and sorting of human myeloperoxidase. Arch Biochem Biophys 445:214–224
Feyler A, Voho A, Bouchardy C et al (2002) Point: myeloperoxidase -463G→ a polymorphism and lung cancer risk. Cancer Epidemiol Biomarkers Prev 11:1550–1554
Schabath MB, Spitz MR, Hong WK et al (2002) A myeloperoxidase polymorphism associated with reduced risk of lung cancer. Lung Cancer 37:35–40
Pakakasama S, Chen TT, Frawley W et al (2003) Myeloperoxidase promotor polymorphism and risk of hepatoblastoma. Int J Cancer 106:205–207
Larsen JE, Colosimo ML, Yang IA et al (2006) CYP1A1 Ile462Val and MPO G-463A interact to increase risk of adenocarcinoma but not squamous cell carcinoma of the lung. Carcinogenesis 27:525–532
Olson SH, Carlson MD, Ostrer H et al (2004) Genetic variants in SOD2, MPO, and NQO1, and risk of ovarian cancer. Gynecol Oncol 93:615–620
Hung RJ, Boffetta P, Brennan P et al (2004) Genetic polymorphisms of MPO, COMT, MnSOD, NQO1, interactions with environmental exposures and bladder cancer risk. Carcinogenesis 25:973–978
Ahn J, Gammon MD, Santella RM et al (2004) Myeloperoxidase genotype, fruit and vegetable consumption, and breast cancer risk. Cancer Res 64:7634–7639
Lin SC, Chou YC, Wu MH et al (2005) Genetic variants of myeloperoxidase and catechol-O-methyltransferase and breast cancer risk. Eur J Cancer Prev 14:257–261
Yang J, Ambrosone CB, Hong CC et al (2007) Relationships between polymorphisms in NOS3 and MPO genes, cigarette smoking and risk of post-menopausal breast cancer. Carcinogenesis 28:1247–1253
Hu YJ, Diamond AM (2003) Role of glutathione peroxidase 1 in breast cancer: loss of heterozygosity and allelic differences in the response to selenium. Cancer Res 63:3347–3351
Sutton A, Khoury H, Prip-Buus C et al (2003) The Ala16Val genetic dimorphism modulates the import of human manganese superoxide dismutase into rat liver mitochondria. Pharmacogenetics 13:145–157
Sutton A, Imbert A, Igoudjil A et al (2005) The manganese superoxide dismutase Ala16Val dimorphism modulates both mitochondrial import and mRNA stability. Pharmacogenet Genomics 15:311–319
Creveling CR (2003) The role of catechol-O-methyltransferase in the inactivation of catecholestrogen. Cell Mol Neurobiol 23:289–291
Guldberg HC, Marsden CA (1975) Catechol-O-methyl transferase: pharmacological aspects and physiological role. Pharmacol Rev 27:135–206
Zhu BT (2002) Catechol-O-Methyltransferase (COMT)-mediated methylation metabolism of endogenous bioactive catechols and modulation by endobiotics and xenobiotics: importance in pathophysiology and pathogenesis. Curr Drug Metab 3:321–349
Lotta T, Vidgren J, Tilgmann C et al (1995) Kinetics of human soluble and membrane-bound catechol O-methyltransferase: a revised mechanism and description of the thermolabile variant of the enzyme. Biochemistry 34:4202–4210
Egan KM, Stampfer MJ, Hunter D et al (2002) Active and passive smoking in breast cancer: prospective results from the Nurses’ Health Study. Epidemiology 13:138–145
Willett WC, Sampson L, Browne ML et al (1988) The use of a self-administered questionnaire to assess diet four years in the past. Am J Epidemiol 127:188–199
Willett W, Stampfer MJ (1986) Total energy intake: implications for epidemiologic analyses. Am J Epidemiol 124:17–27
Hu FB, Stampfer MJ, Rimm E et al (1999) Dietary fat and coronary heart disease: a comparison of approaches for adjusting for total energy intake and modeling repeated dietary measurements. Am J Epidemiol 149:531–540
Willett WC (1998) Nutritional epidemiology. Oxford University Press, New York
Stryker WS, Kaplan LA, Stein EA et al (1988) The relation of diet, cigarette smoking, and alcohol consumption to plasma beta-carotene and alpha-tocopherol levels. Am J Epidemiol 127:283–296
Michaud DS, Giovannucci EL, Ascherio A et al (1998) Associations of plasma carotenoid concentrations and dietary intake of specific carotenoids in samples of two prospective cohort studies using a new carotenoid database. Cancer Epidemiol Biomarkers Prev 7:283–290
El-Sohemy A, Baylin A, Kabagambe E et al (2002) Individual carotenoid concentrations in adipose tissue and plasma as biomarkers of dietary intake. Am J Clin Nutr 76:172–179
Tamimi RM, Hankinson SE, Campos H et al (2005) Plasma carotenoids, retinol, and tocopherols and risk of breast cancer. Am J Epidemiol 161:153–160
Han J, Tranah GJ, Hankinson SE et al (2006) Polymorphisms in O6-methylguanine DNA methyltransferase and breast cancer risk. Pharmacogenet Genomics 16:469–474
Albano E (2006) Alcohol, oxidative stress and free radical damage. Proc Nutr Soc 65:278–290
IARC (2000) Tobacco smoke and involuntary smoking (83). In Monographs on The Evaluation of The Carcinogenic Risk of Chemicals to Humans. IRAC Scientific Publications, Lyon
Piedrafita FJ, Molander RB, Vansant G et al (1996) An Alu element in the myeloperoxidase promoter contains a composite SP1-thyroid hormone-retinoic acid response element. J Biol Chem 271:14412–14420
Reynolds WF, Chang E, Douer D et al (1997) An allelic association implicates myeloperoxidase in the etiology of acute promyelocytic leukemia. Blood 90:2730–2737
Van Schooten FJ, Boots AW, Knaapen AM et al (2004) Myeloperoxidase (MPO) -463G→ A reduces MPO activity and DNA adduct levels in bronchoalveolar lavages of smokers. Cancer Epidemiol Biomarkers Prev 13:828–833
Bekesi G, Kakucs R, Varbiro S et al (2001) Induced myeloperoxidase activity and related superoxide inhibition during hormone replacement therapy. Bjog 108:474–481
Marcozzi FG, Madia F, Del Bianco G et al (2000) Lacrimal fluid peroxidase activity during the menstrual cycle. Curr Eye Res 20:178–182
Reynolds WF, Rhees J, Maciejewski D et al (1999) Myeloperoxidase polymorphism is associated with gender specific risk for Alzheimer’s disease. Exp Neurol 155:31–41
Norris J, Fan D, Aleman C et al (1995) Identification of a new subclass of Alu DNA repeats which can function as estrogen receptor-dependent transcriptional enhancers. J Biol Chem 270:22777–22782
Porter W, Saville B, Hoivik D et al (1997) Functional synergy between the transcription factor Sp1 and the estrogen receptor. Mol Endocrinol 11:1569–1580
Creveling CR (2001) Estrogen metabolism: Does the formation of estrogen quinone provide a potential pathway to breast carcinogenesis? Proceedings of the 9th international catecholamine symposium, Kyoto, Japan
Dawling S, Roodi N, Mernaugh RL et al (2001) Catechol-O-methyltransferase (COMT)-mediated metabolism of catechol estrogens:comparison of wild-type and variant COMT isoforms. Cancer Res 61:6716–6722
Lachman HM, Papolos DF, Saito T et al (1996) Human catechol-O-methyltransferase pharmacogenetics: description of a functional polymorphism and its potential application to neuropsychiatric disorders. Pharmacogenetics 6:243–250
Raftogianis R, Creveling C, Weinshilboum R et al (2000) Estrogen metabolism by conjugation. J Natl Cancer Inst Monogr:113–124
Cavalieri E, Frenkel K, Liehr JG et al (2000) Estrogens as endogenous genotoxic agents–DNA adducts and mutations. J Natl Cancer Inst Monogr:75–93
Yim DS, Parkb SK, Yoo KY et al (2001) Relationship between the Val158Met polymorphism of catechol O-methyl transferase and breast cancer. Pharmacogenetics 11:279–286
Huang CS, Chern HD, Chang KJ et al (1999) Breast cancer risk associated with genotype polymorphism of the estrogen-metabolizing genes CYP17, CYP1A1, and COMT: a multigenic study on cancer susceptibility. Cancer Res 59:4870–4875
Millikan RC, Pittman GS, Tse CK et al (1998) Catechol-O-methyltransferase and breast cancer risk. Carcinogenesis 19:1943–1947
Wen W, Cai Q, Shu XO et al (2005) Cytochrome P450 1B1 and catechol-O-methyltransferase genetic polymorphisms and breast cancer risk in Chinese women: results from the shanghai breast cancer study and a meta-analysis. Cancer Epidemiol Biomarkers Prev 14:329–335
Mitrunen K, Jourenkova N, Kataja V et al (2001) Polymorphic catechol-O-methyltransferase gene and breast cancer risk. Cancer Epidemiol Biomarkers Prev 10:635–640
Hamajima N, Matsuo K, Tajima K et al (2001) Limited association between a catechol-O-methyltransferase (COMT) polymorphism and breast cancer risk in Japan. Int J Clin Oncol 6:13–18
Wedren S, Rudqvist TR, Granath F et al (2003) Catechol-O-methyltransferase gene polymorphism and post-menopausal breast cancer risk. Carcinogenesis 24:681–687
Thompson PA, Shields PG, Freudenheim JL et al (1998) Genetic polymorphisms in catechol-O-methyltransferase, menopausal status, and breast cancer risk. Cancer Res 58:2107–2110
Hu Z, Song CG, Lu JS et al (2007) A multigenic study on breast cancer risk associated with genetic polymorphisms of ER Alpha, COMT and CYP19 gene in BRCA1/BRCA2 negative Shanghai women with early onset breast cancer or affected relatives. J Cancer Res Clin Oncol 133:969–978
Duthie SJ, Ma A, Ross MA et al (1996) Antioxidant supplementation decreases oxidative DNA damage in human lymphocytes. Cancer Res 56:1291–1295
Pool-Zobel BL, Bub A, Muller H et al (1997) Consumption of vegetables reduces genetic damage in humans: first results of a human intervention trial with carotenoid-rich foods. Carcinogenesis 18:1847–1850
Collins AR, Olmedilla B, Southon S et al (1998) Serum carotenoids and oxidative DNA damage in human lymphocytes. Carcinogenesis 19:2159–2162
Torbergsen AC, Collins AR (2000) Recovery of human lymphocytes from oxidative DNA damage; the apparent enhancement of DNA repair by carotenoids is probably simply an antioxidant effect. Eur J Nutr 39:80–85
Acknowledgments
We thank Dr. Hardeep Ranu, Craig Labadie, and Pati Soule for their genotyping assistance, Carolyn Guo and Karen Corsano for their programming support. We also thank the participants in the Nurses’ Health Study for their outstanding dedication and commitment. This work was supported by National Institutes of Health grants CA098233, CA118447, CA065725, USA.
Author information
Authors and Affiliations
Corresponding author
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
He, C., Tamimi, R.M., Hankinson, S.E. et al. A prospective study of genetic polymorphism in MPO, antioxidant status, and breast cancer risk. Breast Cancer Res Treat 113, 585–594 (2009). https://doi.org/10.1007/s10549-008-9962-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10549-008-9962-z